Diabetogia: What was the incidence and relative risk of renal replacement treatment for diabetics and non-diabetic patients in a region of Germany from 2002 to 2016?

At present, there is a lack of information on the trend of end-stage renal disease in diabetic patientsThis study analyzed the incidence and corresponding relative risk of end-stage kidney disease (renal replacement therapy) in diabetic and non-diabetic patientsIn addition, we looked at trends in the 2002-2016 time frameIn this population-based retrospective study, we analyzed data from a dialysis center in a region of Germany that covered about 310,000 residentsWe estimate the age and gender-standardized incidence of chronic renal replacement therapy in adults with and without diabetes, as well as the corresponding relative riskThe time trend is analyzed by Poisson regression modelstudy showed that between 2002 and 2016, 1,107 people (61.2 percent of men); average age of 71.6 years; 48.7 percent of people with diabetes received first-time renal replacement therapyDuring the study period, the incidence of diabetes changed from 93.6 (95% CI 50.4, 136.7) in 2002 to 140.5 (95% CI 80.6, 2000.4) per 100,000 population in 2002Among non-diabetic people, the incidence decreased significantly, reaching 17.3 (95% CI 10.9, 23.6) in 2002 and 24.6 (95% CI 17.5, 31.7) in 2009The relative risk level scored in the diabetes and non-diabetic groups was 3.57 (95% CI 3.09, 4.13), respectivelyDuring the observation period, neither the incidence of diabetics nor non-diabetic patients showed significant changes, and therefore the relative risk remained the samethe fact thatpeople with diabetes are at higher risk of needing kidney replacement treatment than non-diabetic patients has not changed in 15 years